In terms of valuation, Valeant Pharmaceuticals stock currently trades at
TTM price to sales value of 0.58 x and price to book value of 1.40 x.
Not exact matches
This relates to a
price - to - earnings ratio of 36.55 based on a
TTM earnings per share of $ 1.29.
In a more neutral scenario, where OCLR's NOPAT margins compress to 17.5 % (from 21 %
TTM) and it grows revenue by 5 % annually for 10 years, the stock is worth ~ $ 11 / share today — a 65 % premium to the current stock
price.
First, the author compares the
price - to - earnings (P / E) ratio of the S&P 500 ® index based on reported (i.e. net income) trailing twelve month (
TTM) earnings to a 140 - year median value.
As the share
price is falling Express Inc has spent $ 95 million on share repurchases (
TTM) while maintaining zero debt.
Here we will be calculating a
Price - to - Earnings ratio based on trailing - twelve - months (
TTM) earnings.
P / E Ratio —
TTM: Share
price divided by the most recent 12 months» earnings per share from continuing operations.
Free Cash Flow Yield (
ttm): 5.2 % (11/17 points) EV to EBIT (
ttm): 13.4 EV to EBITDA (
ttm): 15.3 (8/17 points)
Price to Sales Ratio (
ttm): 3.4
Price to Book Value (
ttm): 3.2
Price to Earnings Ratio (P / E)(
ttm): n / a PE 10: 19
Free Cash Flow Yield (
ttm): 2.4 % (6/17 points) EV to EBIT (
ttm): 24.6 EV to EBITDA (
ttm): 21.8 (0/17)
Price to Sales Ratio (
ttm): 3.1
Price to Book Value (
ttm): 11.1
Price to Earnings Ratio (P / E)(
ttm): 63 PE 10: 46
Now it appears that we have the same thoughts that the stock
price has further to fall based on your comment above about the
TTM EPS.
I think there's still more pain ahead since the low oil
prices haven't worked their way through
TTM EPS, but I also don't think someone would be unhappy snagging XOM here at this
price when looking back on it in a decade or two.
Free Cash Flow Yield (
ttm): 3.9 % (9/17 points) EV to EBIT (
ttm): 18.7 EV to EBITDA (
ttm): 16.5 (5/17 points)
Price to Sales Ratio (
ttm): 4.1
Price to Book Value (
ttm): n / a
Price to Earnings Ratio (P / E)(
ttm): 31 PE 10: 32
Last
Price: 14.50 p (0.226 USD) Shares outstanding: 67,428,494 Market Cap: 9.8 M GBP (15.25 M USD) Trailing P / E (
ttm): 7.91
Price / Tangible Book (mrq): 0.57
Free Cash Flow Yield (
ttm): 5.0 % (11/17 points) EV to EBIT (
ttm): 19.4 (3/9 points) EV to EBITDA (
ttm): 15.5 (8/17 points)
Price to Sales Ratio (
ttm): 4.5
Price to Book Value (
ttm): 5.7
Price to Earnings Ratio (P / E)(
ttm): 329 PE 10: 28
I define current
price - earnings ratios by the
ttm (trailing twelve months) figures.
Free Cash Flow Yield (
ttm): 3.6 % (9/17 points) EV to EBIT (
ttm): 18.6 EV to EBITDA (
ttm): 14.8 (8/17 points)
Price to Sales Ratio (
ttm): 2.9
Price to Book Value (
ttm): 5.5
Price to Earnings Ratio (P / E)(
ttm): 29 PE 10: 25
The
TTM (trailing 12 - month) stood at Rs. 25.50 per share in December 2015, whereas the P / E (
price - to - earning) ratio stood at 17.96.